According to a recent authoritative research by the LMG Life Sciences Europe Awards*, Legal Alliance was named among five leading Life Sciences law firms recognized in the category The Black Sea Firm of the Year.
The study also noted the professional expertise and achievements of lawyers of the Legal Alliance, who were recognized and nominated in the category of The Lawyer of the Year in certain areas of law:
Managing partner Dmytro Aleshko – Licensing and Collaboration
Partner Oleksiy Bezhevets – Corporate
Partner Andrii Gorbatenko – Competition/Antitrust
Counsel Vitalii Savchuk – Rising Star in Financial and Corporate
According to the research, the Lawyer of the Year awards is based primarily on the role the individual has played on influential cases. This award takes into consideration advocacy, influence, and thought leadership during the period.
The Lawyer of the Year award is based primarily on the personal professional contribution of lawyers and their participation in important cases. This award takes into account the lawyer's skill, influence on results and leadership of opinions during the period under study. The Rising Star Lawyer of the Year award is an associate or of-counsel-level lawyer who is acting at partner level.
In this ranking, the Legal Alliance is recognized alongside world-renowned law firms, which speaks of the professional intelligence and unique projects on which the team of lawyers worked.
* The LMG Life Sciences Awards are part of Euromoney Institutional Investor. The awards are researched and adjudicated by a dedicated awards team that works across range of titles including Benchmark Litigation, Expert Guides, International Financial Law Review, ITR, Managing IP and The Deal. This approach allows us to combine a deep knowledge of the life sciences sector, with expertise in reviewing litigation cases, corporate finance transactions and IP matters.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
